Contact
Please use this form to send email to PR contact of this press release:
GSK and Impax announce positive topline results of ASCEND-PD Phase III study of IPX066 in Advanced Parkinson’s disease
TO:
Please use this form to send email to PR contact of this press release:
GSK and Impax announce positive topline results of ASCEND-PD Phase III study of IPX066 in Advanced Parkinson’s disease
TO: